Heriot-Watt through to the final stage of the Converge Challenge



Steven Hammer (left) with Daniel Good

A Heriot-Watt Research Associate, Steven Hammer, has progressed to the final stage in the Converge Challenge competition.

Palpation Diagnostics has developed a non-invasive diagnostic tool for prostate cancer, and will pitch against five other projects from four other Scottish Universities for their chance to win over £60,000 cash and in-kind business support.

Mervyn Jones, Chair of the Judging Panel, said, “The Judging panel paid tribute to the high standard and excellent quality of business plans submitted this year. All of the judges were impressed with the variety and calibre of start-up ideas which reflect the hard work and determination of University staff and students. We believe this delivers a very positive message about the future of innovation and enterprise within academia to improve economic development in Scotland – a ‘can do’ nation!”

Steven and the other top five finalists progress through to the final stage of the competition – the investor pitch stage. The six Converge Challenge finalists are required to deliver a ten-minute investor pitch to this panel on the 29 September 2015 at the new Technology and Innovation Centre, Glasgow. They will then attend the Awards Dinner where the winners will be announced. The KickStart and Social Enterprise category winners of the Converge Challenge series will also be announced at the Awards Dinner.